Shareholder Information

scroll down

Shares Issued

The number of shares in issue is 22,091,192.

Significant Shareholders

Shareholder No. of ordinary shares % of issued share capital
Crescent Capital II LP 2,652,325 12.01
Viridian Growth Fund LP 1,831,500 8.29
Hargreave Hale Limited 1,402,439 6.35
Amati Global Investors Limited 1,341,463 6.07
Jim Johnston 1,317,325 5.96
Livingbridge VC LLP 1,219,512 5.52
Octopus Investments Limited 1,219,512 5.52
Unicorn AIM VCT plc 1,219,512 5.52
Invest Northern Ireland 974,450 4.41
Crescent Capital III LP 731,707 3.31
QUBIS Limited 709,375 3.21

Director Shareholdings

Director No. of ordinary shares % of issued share capital
Dr Paul Gerard Kerr 1 532,500 2.41
Dr Richard John Buick 515,125 2.33
Dr Simon Gordon Douglas 255,800 1.16
Dr Alan Mawson 2 43,988 0.20
Sonya Maria Ferguson 30,900 0.14
Timothy William Watts 27,575 0.12
Colin James Walsh 3 - -
James Alexander Fair - -

(1) 21,250 of these Ordinary Shares are registered in the name of Paul Kerr's wife, Brigid Kerr.
(2) Alan Mawson is a non-executive director of Clarendon Fund Managers Limited ("Clarendon") and sits on Clarendon's investment committee. Clarendon is the fund manager for Nitech Growth Fund LP which holds 358,850 Ordinary Shares and Viridian Growth Fund LP.
(3) Colin Walsh is the Chief Executive and founder of Crescent Capital NI Limited, which is the fund manager for Crescent Capital II LP and Crescent Capital III LP.

Shares not in public hands

Insofar as it is aware, 45.8% of the Company's securities is not in public hands.

Statement of the Rights of Shareholders

The rights of shareholders are governed by UK law.

Restrictions in transfer of AIM securities

There are no restrictions on the transfer of the Company's ordinary shares.

UK City Code on Takeovers and Mergers

The Company is subject to the provisions of the City Code on Takeover and Mergers.

Other exchanges and trading platforms

Fusion Antibodies has not applied or agreed to have any of its securities admitted or traded on any other exchanges or trading platforms.

Shareholder Circulars

28 August 2018 Chairman's Letter (inc. Notice of AGM to be held on 21 September 2018)


Page last updated: 2 January 2019